Mark E. Issa
Impact in
-
- Adipokines, Inflammation, and Metabolic Diseases
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- Drug Transport and Resistance Mechanisms 2
-
- Phytochemicals and Medicinal Plants 3
- Co-authors
- Kerry B. Goralski (5 shared papers)Christopher J. Sinal (2 shared papers)Matthew C. Ernst (2 shared papers)Muriel Cuendet (9 shared papers)Wim Vanden Berghe (1 shared paper)Claudina Angela Perez-Novo (1 shared paper)Chandra Sekhar Chirumamilla (1 shared paper)Sarah Berndt (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Planta Medica (2 papers)MedChemComm (1 paper)Clinical Epigenetics (1 paper)ACS Omega (1 paper)
- Partner nations
- CanadaSwitzerlandUnited States
In The Last Decade
Mark E. Issa
20 papers receiving 620 citations
Peers
Comparison fields: 5 of 59
- Epidemiology 156
- Oncology 106
- Complementary and alternative medicine 43
- Hematology 39
- Molecular Biology 161
Countries citing papers authored by Mark E. Issa
This map shows the geographic impact of Mark E. Issa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Issa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Issa more than expected).
Fields of papers citing papers by Mark E. Issa
This network shows the impact of papers produced by Mark E. Issa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Issa. The network helps show where Mark E. Issa may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Issa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 223 | |
| 2 | 2017 | 69 | |
| 3 | 2021 | 49 | |
| 4 | 2012 | 38 | |
| 5 | 2015 | 36 | |
| 6 | 2016 | 33 | |
| 7 | 2013 | 31 | |
| 8 | 2017 | 23 | |
| 9 | 2016 | 20 | |
| 10 | 2017 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2024 | 15 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2023 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2017 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2008 | 1 |
About Mark E. Issa
Mark E. Issa is a scholar working on Oncology, Complementary and alternative medicine, Hematology, Immunology and Molecular Biology, having authored 21 papers that have together received 627 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Phytochemicals and Medicinal Plants (3 papers), Multiple Myeloma Research and Treatments (3 papers), T-cell and B-cell Immunology (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Phytochemistry and Biological Activities (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Epidemiology (156 citations), Oncology (106 citations), Complementary and alternative medicine (43 citations), Hematology (39 citations) and Molecular Biology (161 citations). Mark E. Issa has collaborated with scholars based in Canada, Switzerland and United States. Frequent co-authors include Kerry B. Goralski, Christopher J. Sinal, Matthew C. Ernst, Muriel Cuendet, Wim Vanden Berghe, Claudina Angela Perez-Novo, Chandra Sekhar Chirumamilla, Sarah Berndt, Gilles Carpentier and John Michael Pezzuto. Their work appears in journals such as Journal of Clinical Investigation, Planta Medica, MedChemComm, Clinical Epigenetics and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.